Belgium's MDxHealth signs U.S. deal for cancer test
BRUSSELS (Reuters) - Belgian biotech firm MDxHealth has signed a deal with U.S. healthcare network Stratose, which will give its prostate cancer testing product access to one of the largest networks in the United States.
MDxHealth said on Tuesday that with the signature of the Stratose agreement 80 million people in the United States will now have access to its prostate cancer test.
(Reporting by Robert-Jan Bartunek)
WASHINGTON - Start-up companies will be able to raise much more capital through certain public stock deals without facing costly regulatory burdens under a proposal announced by U.S. securities regulators on Wednesday.
BEIJING/HONG KONG - China reiterated its opposition on Thursday to a European Union plan to limit airline carbon dioxide emissions and called for talks to resolve the issue a day after its major airlines refused to pay any carbon costs under the new law.